Reference 2019-330

REF:         2019-330  

Subject:     Wet Age Related Macular Degeneration  



Within your trust how many intra-vitreal injections/implants have been used in the latest 4 months, if possible between January and April 2019

If your trust is able to identify injections/implants by eye conditions please split by the drug used [ranibizumab, bevacizumab, aflibercept, Fluocinolone and Dexamethasone].




We are unable to provide data for individual conditions.


The following were issued between 01/01/2019 and 30/04/2019:

  Lucentis (ranibizumab) Injections Avastin (bevacizumab) Injections Eylea (aflibercept) Injections Illuvien (Fluocinolone) Impants Ozudex (Dexamethasone) Implants
Total 862 0 959 0 21